The hybrid oncogene of BCR-ABL is the main cause of CML development by controlling processes like cell proliferation, adhesion and survival.   31  The chronic primary phase of the disease is gradually changed to invasive phase followed by blastic phase or blast crisis. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.